A black and blue at the right arm injection site which is ongoing but fading; Hypersensitivity reaction; Low grade fever; Chills; Body aches; Splitting headache; Extreme fatigue; Muscle of the injection site was stiff; Making it hard to raise arm and move the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (A black and blue at the right arm injection site which is ongoing but fading), MUSCULOSKELETAL STIFFNESS (Muscle of the injection site was stiff), MOVEMENT DISORDER (Making it hard to raise arm and move the arm), HYPERSENSITIVITY (Hypersensitivity reaction) and FATIGUE (Extreme fatigue) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 027C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Vein disorder (clogged lower veins), Vascular disorder NOS (Vascular issues), Allergy to animals (Patient stated she had numerous allergy shots many years ago in the same arm due to cat allergy), Hypertension since 2003, Hyperlipidemia (Hyperlipidity) since 2003, Hypersensitivity, Hives (Hives/urticaria), Asthma, Hay fever, Allergy to antibiotic (Ampicillin allergy felt ill, nauseous) since 1990, Sulfonamide allergy (Sulfa drugs allergy- difficulty breathing) since 1990, Allergy to nuts (Almond allergy-swelling of tongue, mild to moderate) since 1990, Drug allergy (Cillin medicines-no antibiotic reaction, caused nausea.) since 1990, Fragrance sensitivity (Chemical fragrances-caused some allergic asthma,  issue has mostly gone/resolved) since 2000, Type 2 diabetes mellitus since 2004, Neuropathy, Osteoarthritis since 2006, LBBB (LBBB - left bundle branch block) since 2006 and Carpal tunnel syndrome (Carpal tunnel syndrome-more painful) since 1998. Concomitant products included LOSARTAN POTASSIUM from 2003 to an unknown date and LABETALOL from 2003 to an unknown date for Blood pressure management, SIMVASTATIN from 2003 to an unknown date for Cholesterol, UBIQUINOL for Energy increased, GABAPENTIN from 2006 to an unknown date for Pain, IRON for Supplementation therapy, METFORMIN HCL from 2004 to an unknown date for Type 2 diabetes mellitus, HORSE CHESTNUT EXTRACT for Vein disorder.   On 02-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Jun-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Muscle of the injection site was stiff), MOVEMENT DISORDER (Making it hard to raise arm and move the arm) and FATIGUE (Extreme fatigue). On 03-Jun-2021, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction), PYREXIA (Low grade fever), CHILLS (Chills), MYALGIA (Body aches) and HEADACHE (Splitting headache). On 06-Jun-2021, the patient experienced VACCINATION SITE BRUISING (A black and blue at the right arm injection site which is ongoing but fading). The patient was treated with VITIS VINIFERA SEED (GRAPE SEED EXTRACT [VITIS VINIFERA SEED]) ongoing since an unknown date for Vascular disorder NOS, at a dose of 1 dosage form. On 03-Jun-2021, MUSCULOSKELETAL STIFFNESS (Muscle of the injection site was stiff) and MOVEMENT DISORDER (Making it hard to raise arm and move the arm) had resolved. On 04-Jun-2021, HYPERSENSITIVITY (Hypersensitivity reaction), FATIGUE (Extreme fatigue), PYREXIA (Low grade fever), CHILLS (Chills), MYALGIA (Body aches) and HEADACHE (Splitting headache) had resolved. At the time of the report, VACCINATION SITE BRUISING (A black and blue at the right arm injection site which is ongoing but fading) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: within normal limit mmHg (normal) Normal.         Other concomitant medications included blood pressure pill, cholesterol pill, pain blocker, facial oil that has anchovies oil, key lime flavor and sardine oil. Treatment information was not provided.    This case was linked to MOD-2021-256773 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Added patient demographics, medical history and lab test. Added second dosage details. Added vaccine facility information. Added concomitant drugs. Added new events.